Bharat Parenterals Share Price Today | Stock Price & Bharat Parenterals Share Screener
As of October 5, 2026, the live Bharat Parenterals share price (NSE: BPLPHARMA) is ₹1,726.90 on NSE and ₹1,727.30 on BSE, up 0.38% from the previous close, with shares trading between ₹1,670.00 and ₹1,790.00 in today's trading session, and a 52-week range of ₹1,264.80–₹2,149.80. Check BPLPHARMA price range for the annual price range and momentum. Use the Bharat Parenterals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Bharat Parenterals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹106 and net income of ₹-9, with EBITDA of ₹4, an operating margin of 2.0% and a profit margin of -8.5%.
Bharat Parenterals Share Price Chart
Track the current stock price of Bharat Parenterals with an interactive chart. Analyse BPLPHARMA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Bharat Parenterals stock quote in one place.
The quote of ₹1,726.90 sits between the 52-week low of ₹1,264.80 and the 52-week high of ₹2,149.80, and the latest session moved 0.38% from the previous close.
Bharat Parenterals Company Profile - Fundamental Screener
Screen Bharat Parenterals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BPLPHARMA shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE365Y01019.
Company Details
Classification
Identifiers and Leadership
Bharat Parenterals Balance Sheet Screener
Screen BPLPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹649 against total liabilities of ₹649, up from ₹504 in 2024.
Latest statistics put total assets at ₹649 and shareholder funds at ₹339, with a leverage ratio of 0.64.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 649 | 504 | 350 | 226 | 199 | 188 | 159 | 132 | 111 | 120 |
| Current Assets | 356 | 260 | 184 | 144 | 148 | 132 | 118 | 91 | 64 | 72 |
| Fixed Assets | 252 | 210 | 42 | 41 | 45 | 33 | 35 | 34 | 31 | 35 |
Liabilities |
||||||||||
| Total Liabilities | 649 | 504 | 350 | 226 | 199 | 188 | 159 | 132 | 111 | 120 |
| Current Liabilities | 90 | 75 | 13 | 14 | 11 | 3 | 4 | 2 | 4 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 339 | 238 | 218 | 170 | 144 | 118 | 94 | 73 | 64 | 57 |
| Share Capital | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 324 | 191 | 177 | 160 | 138 | 113 | 88 | 67 | 58 | 51 |
Bharat Parenterals Income Statement Screener - Profit & Revenue Analysis
Screen Bharat Parenterals income statement and profit fundamentals. Analyze BPLPHARMA quarterly results. Bharat Parenterals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2025-Mar, revenue was ₹106 and net profit was ₹-9, equal to earnings per unit of ₹-14.40, at an operating margin of 2%.
In that period expenses were ₹102, interest cost ₹4 and tax ₹1. The next period listed, 2025-Jun, shows revenue of ₹117 and net profit of ₹-1.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 106 | 117 | 68 | 71 | 95 | 76 | 75 | 51 | 72 | 62 | 61 | 55 | 28 | 88 | 63 |
| Expenses | 102 | 102 | 64 | 67 | 88 | 79 | 69 | 45 | 60 | 56 | 53 | 48 | 24 | 73 | 56 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 4 | 15 | 4 | 4 | 7 | -4 | 7 | 7 | 13 | 7 | 8 | 7 | 3 | 16 | 6 |
| Operating Profit % | 2.00% | 12.00% | 1.00% | 1.00% | 5.00% | -11.00% | 5.00% | 12.00% | 15.00% | 7.00% | 11.00% | 8.00% | 7.00% | 11.00% | 4.00% |
| Depreciation | 9 | 9 | 9 | 4 | 9 | 9 | 9 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Interest | 4 | 4 | 3 | 1 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | -8 | 3 | -7 | -1 | -5 | -15 | -6 | 4 | 10 | 5 | 6 | 5 | 2 | 14 | 4 |
| Tax | 1 | 3 | 1 | 1 | 4 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 0 | 4 | 1 |
| Net Profit | -9 | -1 | -9 | -3 | -9 | -18 | -8 | 2 | 7 | 2 | 4 | 4 | 1 | 10 | 3 |
| EPS | -14.40 | -1.00 | -14.00 | -0.62 | -2.11 | -27.00 | -10.00 | 4.24 | 13.03 | 6.07 | 6.45 | 7.04 | 2.03 | 17.19 | 4.94 |
Bharat Parenterals Cash Flow Screener - Liquidity Fundamentals
Screen BPLPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities used ₹27, and net cash flow was an outflow of ₹8.
Over the same period, investing activities used ₹137 and financing activities provided ₹156.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -27 | -5 | 22 | -1 | 25 | 14 | 20 | 6 | -2 | 0 |
| Investing Activities | -137 | -105 | -78 | -7 | -43 | -13 | -9 | -8 | -2 | 0 |
Financing and Net Cash | ||||||||||
| Financing Activities | 156 | 110 | 61 | 9 | 11 | -3 | -4 | 4 | -8 | 0 |
| Net Cash Flow | -8 | 1 | 4 | 2 | -8 | -1 | 7 | 2 | -11 | 0 |
Bharat Parenterals Shareholding Pattern Screener
See Bharat Parenterals shareholding pattern with promoter, FII, and DII holdings. Check Bharat Parenterals promoter holding and ownership changes for BPLPHARMA on TickJournal, and see how institutional stock price moves affect the market.
In 2025-Mar, promoters held 67.20%, foreign institutions 0.11%, domestic institutions 0.54% and the public 18.94%, spread across 3,177 shareholders.
The shareholder count was 3,177 in 2025-Mar, compared with 3,231 in 2025-Jun.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Oct | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 67.20% | 67.19% | 67.19% | 73.26% | 73.27% | 65.35% | 67.20% | 67.20% |
Institutional Investors | ||||||||
| FII Holding | 0.11% | 0.11% | 0.11% | 0.00% | 0.00% | 0.08% | 0.08% | 0.11% |
| DII Holding | 0.54% | 0.54% | 0.54% | 0.01% | 0.01% | 0.57% | 0.54% | 0.54% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.94% | 19.31% | 19.27% | 13.61% | 13.60% | 20.07% | 19.00% | 19.20% |
| Other Holding | 13.21% | 12.85% | 12.89% | 13.11% | 13.13% | 13.92% | 13.18% | 12.95% |
| Shareholder Count | 3,177 | 3,231 | 3,205 | 2,497 | 2,727 | 2,748 | 2,750 | 3,116 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Bharat Parenterals. Bharat Parenterals dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹1.00 per unit for 2025-March, a yield of 0.08%, compared with ₹1.00 for 2024-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹1.00, ₹1.00 and ₹0.75 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹1.00 | 0.08% |
| 2024-March | ₹1.00 | 0.10% |
| 2023-March | ₹0.75 | 0.07% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Bharat Parenterals Stock Index Membership - Nifty & Sensex
See which indices include Bharat Parenterals stock. Check BPLPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Bharat Parenterals Market Events Screener - Corporate Actions
Get Bharat Parenterals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Bharat Parenterals stock events that may affect BPLPHARMA share price, along with derivatives, futures and options activity and sector gainers.
11 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 12, 2025, with a record date of November 12, 2025.
It is followed by Annual General Meeting dated September 26, 2025 and Dividend dated September 19, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -10.23% |
| 2025-09-26 | 2025-09-26 | Annual General Meeting | NA | -4.06% |
| 2025-09-19 | 2025-09-19 | Dividend | ₹ 1.00 /share | 21.17% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | 10.26% |
| 2025-02-03 | 2025-02-03 | Quarterly Result Announcement | NA | -7.55% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -5.87% |
| 2024-07-02 | 2024-07-02 | Annual General Meeting | NA | 6.46% |
| 2024-06-25 | 2024-06-25 | Dividend | ₹ 1.00 /share | -3.36% |
| 2024-05-21 | 2024-05-21 | Extraordinary General Meeting | NA | -11.42% |
| 2023-09-25 | 2023-09-25 | Dividend | ₹ 0.75 /share | 68.09% |
Bharat Parenterals Competitors Screener - Peer Stocks Comparison
Screen BPLPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Bharat Parenterals Company Announcements - News & Reports Screener
Screen BPLPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated December 10, 2025.
The next most recent announcements are dated December 9, 2025 and December 4, 2025.
| Date | Update | Actions |
|---|---|---|
| 2025-12-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-12-09 | Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window. | - |
| 2025-12-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-11-25 | Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window. | - |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 | - |
| 2025-11-12 | For The Quarter And Half Year Ended September 30 2025 | - |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2025-11-12 | Board Meeting Outcome for For Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025. | - |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-06 | Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On September 30 2025. | - |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹1,726.90, within a 52-week range of ₹1,264.80 to ₹2,149.80. The P/E ratio is 15.00 and the P/B ratio is 2.54, with earnings per unit of ₹-66.64. Market capitalisation stands at ₹842.19 Cr and the dividend yield is 0.08%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.